Altogether, we demonstrate that MYC facilitates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma, contributing to poor survival and chemoresistance. This evidence concerns the gene MYC and pancreatic ductal adenocarcinoma.